Truist Financial’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Sell
59,753
-2,557
-4% -$130K ﹤0.01% 1170
2026
Q1
$3.32M Sell
62,310
-6,457
-9% -$379K ﹤0.01% 1044
2025
Q4
$4.27M Sell
68,767
-2,937
-4% -$181K 0.01% 929
2025
Q3
$4.31M Buy
71,704
+462
+0.6% +$28.3K 0.01% 958
2025
Q2
$4.46M Sell
71,242
-6,264
-8% -$376K 0.01% 909
2025
Q1
$4.67M Sell
77,506
-25,197
-25% -$1.57M 0.01% 865
2024
Q4
$5.99M Sell
102,703
-14,356
-12% -$853K 0.01% 758
2024
Q3
$6.93M Sell
117,059
-20,703
-15% -$1.18M 0.01% 713
2024
Q2
$7.72M Sell
137,762
-4,711
-3% -$264K 0.01% 689
2024
Q1
$8.35M Sell
142,473
-13,537
-9% -$765K 0.01% 692
2023
Q4
$8.42M Buy
156,010
+1,582
+1% +$77.3K 0.01% 678
2023
Q3
$7.49M Buy
154,428
+4,107
+3% +$218K 0.01% 683
2023
Q2
$8.49M Buy
150,321
+886
+0.6% +$48.8K 0.01% 645
2023
Q1
$8.07M Sell
149,435
-8,623
-5% -$459K 0.01% 656
2022
Q4
$8.31M Sell
158,058
-20,782
-12% -$1.05M 0.01% 639
2022
Q3
$8.44M Sell
178,840
-3,341
-2% -$173K 0.02% 612
2022
Q2
$9.19M Sell
182,181
-169,164
-48% -$9.22M 0.02% 597
2022
Q1
$21.4M Buy
351,345
+160,566
+84% +$9.57M 0.03% 406
2021
Q4
$12.6M Sell
190,779
-3,761
-2% -$241K 0.02% 568
2021
Q3
$12.2M Buy
194,540
+14,330
+8% +$914K 0.02% 566
2021
Q2
$10.8M Sell
180,210
-68,910
-28% -$3.99M 0.02% 604
2021
Q1
$13.7M Sell
249,120
-42,000
-14% -$2.33M 0.02% 515
2020
Q4
$15.9M Buy
291,120
+10,296
+4% +$538K 0.03% 469
2020
Q3
$14M Sell
280,824
-8,232
-3% -$399K 0.03% 455
2020
Q2
$12.8M Buy
289,056
+11,760
+4% +$503K 0.03% 471
2020
Q1
$10.4M Sell
277,296
-15,120
-5% -$637K 0.03% 477
2019
Q4
$12.9M Buy
+292,416
New +$12.3M 0.03% 506

Other funds holding IHI

Truist Financial's IHI Position: Q2 2026 in Review

Truist Financial reduced its iShares US Medical Devices ETF (IHI) stake by 4.1% in Q2 2026, selling an estimated $130K and leaving 59,753 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Truist Financial first reported a position in IHI in Q4 2019 and has held it in 27 quarters since. The position peaked at $21.4M in Q1 2022. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Truist Financial held 59,753 shares of iShares US Medical Devices ETF worth $2.95M as of Q2 2026.
  • Truist Financial sold 2,557 iShares US Medical Devices ETF shares in Q2 2026, an estimated $130K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1170 holding.
  • Truist Financial first reported a position in iShares US Medical Devices ETF in Q4 2019 and has held it in 27 quarters since.
  • Truist Financial's iShares US Medical Devices ETF position peaked at $21.4M in Q1 2022.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.